Patents by Inventor Gerald Lasser

Gerald Lasser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060252692
    Abstract: The present invention relates to peptide, polynucleotide and fusion proteins for use as inhibitors in hemostasis. These inhibitors are members of the family of proteins bearing a collagen-like domain and a globular domain. The inhibitors are useful for promoting blood flow in the vasculature by reducing thrombogenic and complement activity. The inhibitors are also useful for pacify collagenous surfaces and modulating wound healing.
    Type: Application
    Filed: June 29, 2006
    Publication date: November 9, 2006
    Inventors: Gerald Lasser, Paul Bishop, Joachim Fruebis, Woerner Meehan
  • Publication number: 20020110554
    Abstract: Tissue sealant compositions containing human recombinant fibrinogen, human recombinant factor XIII and human recombinant thrombin. Also disclosed are preferred formulations and uses therefore.
    Type: Application
    Filed: January 17, 2002
    Publication date: August 15, 2002
    Inventors: Kenneth B. Lewis, Paul A. Brown, Gerald Lasser, Paul D. Bishop
  • Patent number: 5834232
    Abstract: Enzymatically cross-linked protein gels and methods for preparing them are disclosed. The methods comprise adding a transglutaminase, such as factor XIII, to a composition of a temperature-sensitive gel-forming protein, such as gelatin or collagen, and incubating the composition and transglutaminase under gel-forming conditions. The resulting gels have superior strength and thermal stability, and can be used within a variety of medical and industrial applications.
    Type: Grant
    Filed: May 1, 1996
    Date of Patent: November 10, 1998
    Assignee: ZymoGenetics, Inc.
    Inventors: Paul D. Bishop, Gerald Lasser